Clinical data | |
---|---|
Trade names | Halog |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a682272 |
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.019.490 |
Chemical and physical data | |
Formula | C24H32ClFO5 |
Molar mass | 454.96 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Halcinonide is a high potency corticosteroid, in group II (second most potent group) under US classification. It is used topically (in a 0.05% cream provided as Halog) in the treatment of certain skin conditions. It is available as a generic medication.
References
- Pujos E, Flament-Waton MM, Paisse O, Grenier-Loustalot MF (January 2005). "Comparison of the analysis of corticosteroids using different techniques". Anal Bioanal Chem. 381 (1): 244–54. doi:10.1007/s00216-004-2890-9. PMID 15700162. S2CID 19561444.
- "First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 8 July 2024. Retrieved 9 July 2024.
Glucocorticoids and antiglucocorticoids (D07, H02) | |
---|---|
Glucocorticoids | |
Antiglucocorticoids |
|
Synthesis modifiers | |
|
This dermatologic drug article is a stub. You can help Misplaced Pages by expanding it. |